These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 23399651)

  • 41. Vitamin D status and sex hormone binding globulin: determinants of bone turnover and bone mineral density in elderly women.
    Ooms ME; Lips P; Roos JC; van der Vijgh WJ; Popp-Snijders C; Bezemer PD; Bouter LM
    J Bone Miner Res; 1995 Aug; 10(8):1177-84. PubMed ID: 8585420
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Do sex hormones influence features of the metabolic syndrome in middle-aged women? A population-based study of Swedish women: the Women's Health in the Lund Area (WHILA) Study.
    Shakir YA; Samsioe G; Nyberg P; Lidfeldt J; Nerbrand C; Agardh CD
    Fertil Steril; 2007 Jul; 88(1):163-71. PubMed ID: 17383645
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Risk factors for lower urinary tract symptoms suggestive of benign prostatic hyperplasia in a community based population of healthy aging men: the Krimpen Study.
    Kok ET; Schouten BW; Bohnen AM; Groeneveld FP; Thomas S; Bosch JL
    J Urol; 2009 Feb; 181(2):710-6. PubMed ID: 19091352
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Sex steroid hormones and the androgen receptor gene CAG repeat and subsequent risk of prostate cancer in the prostate-specific antigen era.
    Platz EA; Leitzmann MF; Rifai N; Kantoff PW; Chen YC; Stampfer MJ; Willett WC; Giovannucci E
    Cancer Epidemiol Biomarkers Prev; 2005 May; 14(5):1262-9. PubMed ID: 15894683
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Serum steroids in relation to benign prostatic hyperplasia.
    Lagiou P; Mantzoros CS; Tzonou A; Signorello LB; Lipworth L; Trichopoulos D
    Oncology; 1997; 54(6):497-501. PubMed ID: 9394847
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Relationship between serum sex hormones levels and degree of benign prostate hyperplasia in Chinese aging men.
    Zeng QS; Xu CL; Liu ZY; Wang HQ; Yang B; Xu WD; Jin TL; Wu CY; Huang G; Li Z; Wang B; Sun YH
    Asian J Androl; 2012 Sep; 14(5):773-7. PubMed ID: 22751417
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Association between prostatic resistive index and cardiovascular risk factors in patients with benign prostatic hyperplasia.
    Baykam MM; Aktas BK; Bulut S; Ozden C; Deren T; Tagci S; Gokkaya CS; Memis A
    Kaohsiung J Med Sci; 2015 Apr; 31(4):194-8. PubMed ID: 25835275
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Lipids, lipoproteins and the risk of benign prostatic hyperplasia in community-dwelling men.
    Parsons JK; Bergstrom J; Barrett-Connor E
    BJU Int; 2008 Feb; 101(3):313-8. PubMed ID: 18005202
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Hyperinsulinaemia as a risk factor for developing benign prostatic hyperplasia.
    Hammarsten J; Högstedt B
    Eur Urol; 2001 Feb; 39(2):151-8. PubMed ID: 11223674
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Prostatic distribution of sex hormone-binding globulin and cortisol-binding globulin in benign hyperplasia.
    Cowan RA; Cowan SK; Giles CA; Grant JK
    J Endocrinol; 1976 Oct; 71(1):121-31. PubMed ID: 62006
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Metabolic syndrome and benign prostatic hyperplasia: association or coincidence?
    Rył A; Rotter I; Miazgowski T; Słojewski M; Dołęgowska B; Lubkowska A; Laszczyńska M
    Diabetol Metab Syndr; 2015; 7():94. PubMed ID: 26516352
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Influence of age and endocrine factors on the volume of benign prostatic hyperplasia.
    Partin AW; Oesterling JE; Epstein JI; Horton R; Walsh PC
    J Urol; 1991 Feb; 145(2):405-9. PubMed ID: 1703242
    [TBL] [Abstract][Full Text] [Related]  

  • 53. White blood cell count is positively associated with benign prostatic hyperplasia.
    Fujita K; Hosomi M; Nakagawa M; Tanigawa G; Imamura R; Uemura M; Nakai Y; Takayama H; Yamaguchi S; Nonomura N
    Int J Urol; 2014 Mar; 21(3):308-12. PubMed ID: 23980666
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Deficiency of vitamin D and elevated aldosterone in prostate hyperplasia.
    Yalçınkaya S; Eren E; Eroglu M; Aydin O; Yilmaz N
    Adv Clin Exp Med; 2014; 23(3):441-6. PubMed ID: 24979517
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Benign prostatic enlargement can be influenced by metabolic profile: results of a multicenter prospective study.
    Gacci M; Sebastianelli A; Salvi M; De Nunzio C; Vignozzi L; Corona G; Jaeger T; Chini T; Russo GI; Maggi M; Morgia G; Tubaro A; Carini M; Serni S
    BMC Urol; 2017 Apr; 17(1):22. PubMed ID: 28376747
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Hypoadiponectinemia, elevated iron and high-sensitivity C-reactive protein levels and their relation with prostate size in benign prostatic hyperplasia.
    Nandeesha H; Eldhose A; Dorairajan LN; Anandhi B
    Andrologia; 2017 Sep; 49(7):. PubMed ID: 27658341
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Challenging the Inevitability of Prostate Enlargement: Low Levels of Benign Prostatic Hyperplasia Among Tsimane Forager-Horticulturalists.
    Trumble BC; Stieglitz J; Eid Rodriguez D; Cortez Linares E; Kaplan HS; Gurven MD
    J Gerontol A Biol Sci Med Sci; 2015 Oct; 70(10):1262-8. PubMed ID: 25922348
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Can metabolic disorders in aging men contribute to prostatic hyperplasia eligible for transurethral resection of the prostate (TURP)?
    Rył A; Rotter I; Słojewski M; Jędrzychowska A; Marcinowska Z; Grabowska M; Laszczyńska M
    Int J Environ Res Public Health; 2015 Mar; 12(3):3327-42. PubMed ID: 25809513
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Changes of sex hormones and risk factors associated with atherosclerosis in old patients with castrated prostatic cancer].
    Xu K; Si QJ
    Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2013 Jul; 29(4):368-70, 375. PubMed ID: 24175566
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Metabolic factors associated with benign prostatic hyperplasia.
    Parsons JK; Carter HB; Partin AW; Windham BG; Metter EJ; Ferrucci L; Landis P; Platz EA
    J Clin Endocrinol Metab; 2006 Jul; 91(7):2562-8. PubMed ID: 16608892
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.